The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson’s Disease: A Feasibility Study

Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson’s Disease

(2019) Mark Dominic Latt et al.   DRUGS & AGING

Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor

(2018) David L. Gray et al.   Nature Communications

Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization

(2018) Jennifer E. Davoren et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Pilgrim's Journey—When Parkinson's Disease Comes to an End in Nursing Homes

(2018) Katharina Maria Lex et al.   Frontiers in Neurology

Progression of prodromal motor and non-motor symptoms in the premotor phase study - 2-year follow-up data

(2017) I. Liepelt-Scarfone et al.   EUROPEAN JOURNAL OF NEUROLOGY

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort

(2017) Danna Jennings et al.   JAMA Neurology

Levodopa therapy for Parkinson disease: Table

(2016) Peter A. LeWitt et al.   NEUROLOGY

Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure

(2015) Amy C. Arnold et al.   HYPERTENSION

Parkinson's disease beyond 20 years

(2014) Roberto Cilia et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder

(2014) Daniel R Rosell et al.   NEUROPSYCHOPHARMACOLOGY

The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling

(2013) Lisa Kuramoto et al.   PLoS One

Clinical aspects of palliative care in advanced Parkinson’s disease

(2012) Johan Lokk et al.   BMC Palliative Care

Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial

(2010) James A. Tumlin et al.   ACADEMIC EMERGENCY MEDICINE

Neurotransmission in Parkinson’s disease: beyond dopamine

(2009) P. Barone   EUROPEAN JOURNAL OF NEUROLOGY